eEF2K alleviates doxorubicin-induced cardiotoxicity by inhibiting GSK3β and improving autophagy dysfunction
Cell Biology and Toxicology · 2024
DOI: 10.1007/s10565-024-09966-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology and Toxicology, 2024. Verfasst von Junjie Guan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, No 253, Middle Gongye Avenue, 510282, Guangzhou…. Hauptthemen laut MEDLINE: Autophagy, Elongation Factor 2 Kinase, Doxorubicin, Glycogen Synthase Kinase 3 beta. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Postdoctoral Science Foundation under Grant, Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Doxorubicin-induced cardiotoxicity (DIC) poses a threat to the health and prognosis of cancer patients. It is important to find a safe and effective method for the prevention and treatment of DIC. eEF2K, which is a highly conserved α-kinase, is thought to be a therapeutic target for several human diseases. Nonetheless, it is still uncertain if eEF2K contributes to the cardiotoxic effects caused by doxorubicin (DOX). Our research revealed that eEF2K expression decreased in the DIC. eEF2K was overexpressed through adeno-associated virus in vivo and adenovirus in vitro, which presented alleviative cardiomyocyte death and cell atrophy induced by DOX. Autophagy dysfunction is one of important mechanisms in DIC. As a result, autophagic function was evaluated using Transmission electron microscopy in vivo, as well as LysoSensor and mRFPGFP-LC3 puncta in vitro. eEF2K overexpression improves DOX-induced autophagy blockade. In addition, eEF2K knockdown aggravated autophagy blockade and cardiomyocyte injury in DIC model. eEF2K also phosphorylated and inhibited GSK3β in DIC model. AR-A014418 (ARi), known for selectively inhibiting GSK3β, countered the effects of eEF2K knockdown, which aggravated autophagy blockade in the DIC. In conclusion, this study proposes that eEF2K alleviates DIC by inhibiting GSK3β and improving autophagy dysfunction. eEF2K is a promising therapeutic target against DIC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, No 253, Middle Gongye Avenue, 510282, Guangzhou, Guangdong, People's Republic of China.
- Heart Center of Zhujiang Hospital, Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, Guangzhou, Guangdong, People's Republic of China.
- Heart Center of Zhujiang Hospital, Sino-Japanese Cooperation Platform for Translational Research in Heart Failure, Guangzhou, Guangdong, People's Republic of China.
- Department of Cardiology, Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, No 253, Middle Gongye Avenue, 510282, Guangzhou, Guangdong, People's Republic of China. 1834043611@qq.com.
- Heart Center of Zhujiang Hospital, Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, Guangzhou, Guangdong, People's Republic of China. 1834043611@qq.com.
- Heart Center of Zhujiang Hospital, Sino-Japanese Cooperation Platform for Translational Research in Heart Failure, Guangzhou, Guangdong, People's Republic of China. 1834043611@qq.com.
Förderung
- China Postdoctoral Science Foundation under Grant
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Guan, J., Mo, H., Virak, V., Guo, R., Que, D., Yu, W., Zhang, X., Yan, J., Wang, Y., Yang, Y., Rui, B., Huang, G., Chen, D., Zhong, C., & Yang, P. (2024). eEF2K alleviates doxorubicin-induced cardiotoxicity by inhibiting GSK3β and improving autophagy dysfunction. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-024-09966-2
Vancouver
Guan J, Mo H, Virak V, Guo R, Que D, Yu W, et al. eEF2K alleviates doxorubicin-induced cardiotoxicity by inhibiting GSK3β and improving autophagy dysfunction. Cell Biology and Toxicology. 2024. doi:10.1007/s10565-024-09966-2
BibTeX
@article{Guan2024,
author = {Guan, Junjie and Mo, Hongwei and Virak, Vicheth and Guo, Runze and Que, Dongdong and Yu, Wenjie and Zhang, Xuwei and Yan, Jing and Wang, Yuxi and Yang, Yashu and Rui, Bowen and Huang, Guanlin and Chen, Deshu and Zhong, Chongbin and Yang, Pingzhen},
title = {eEF2K alleviates doxorubicin-induced cardiotoxicity by inhibiting GSK3β and improving autophagy dysfunction},
journal = {Cell Biology and Toxicology},
year = {2024},
doi = {10.1007/s10565-024-09966-2}
}
EUVIMED